Correction: Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—A clinical pilot study

Correction: Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—A clinical pilot study

Saved in:

Bibliographic Details
Main Author:	Frontiers Production Office
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Medicine
Subjects:	ME/CFS clinical trial daratumumab autoantibodies plasma cell feasibility pathomechanism
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1677216/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Beneficial effects of intermittent intravenous saline infusion in dysautonomic patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: a case-series
by: Per Sjögren, et al.
Published: (2025-07-01)

Advocating the role of trained immunity in the pathogenesis of ME/CFS: a mini review
by: Bart Humer, et al.
Published: (2025-03-01)

SMPDL3B a novel biomarker and therapeutic target in myalgic encephalomyelitis
by: Bita Rostami-Afshari, et al.
Published: (2025-07-01)

Bleeding Diathesis Secondary to a Heparin-Like Anticoagulant in a Patient with Multiple Myeloma—A Case Report and Review of Literature
by: Nihar Desai, et al.
Published: (2024-02-01)

Pathological mechanisms and treatment progression of Alzheimer’s disease
by: Jingjing Zhang, et al.
Published: (2025-07-01)

Fatigue, interoplastic and nociplastic distress in myalgic encephalomyelitis/chronic fatigue syndrome, Gulf War Illness, and chronic idiopathic fatigue
by: Emily Chen, et al.
Published: (2025-08-01)

Myalgic Encephalomyelitis: A legal guide to the perplexed
by: W.P. de Villiers
Published: (2005-08-01)

Correction: Capacity building of primary healthcare providers in Rajasthan, India, for screening and management of common mental health disorders: a study protocol
by: Frontiers Production Office
Published: (2025-08-01)

Unravelling the Connection Between Energy Metabolism and Immune Senescence/Exhaustion in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Jente Van Campenhout, et al.
Published: (2025-03-01)

Replicated blood-based biomarkers for myalgic encephalomyelitis not explicable by inactivity
by: Sjoerd Viktor Beentjes, et al.
Published: (2025-06-01)

Todd’s Paresis as a Post Ictal Phenomenon in Post-Traumatic Epilepsy: A Case Report
by: I Gusti Agung Ayu Andra Yusari, et al.
Published: (2025-07-01)

Exploring barriers and facilitators to effective self-management in individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an Interpretative Phenomenological Analysis
by: Molly Roberts, et al.
Published: (2025-12-01)

Treatment of double-refractory multiple myeloma
by: S. V. Semochkin
Published: (2021-09-01)

Decreased risk of chronic fatigue syndrome following influenza vaccine: a 20-year population-based retrospective study
by: Hsun Chang, et al.
Published: (2025-07-01)

Practice-changing updates on multiple myeloma: highlights from the 2024 ASH annual meeting
by: Ioannis Ntanasis-Stathopoulos, et al.
Published: (2025-05-01)

Association of Active Human Herpesvirus-6, -7 and Parvovirus B19 Infection with Clinical Outcomes in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
by: Svetlana Chapenko, et al.
Published: (2012-01-01)

Axial strength of back to back cold formed steel short channel sections with unstiffened and stiffened web holes
by: Ardalan B. Hussein, et al.
Published: (2025-08-01)

Association Between Thyroid Antibodies and Ultrasonic Imaging in Patients with Hashimoto’s Thyroiditis
by: Mustafa Unal, et al.
Published: (2022-11-01)

Recommendations for optimising pilot and feasibility work in surgery
by: K. Fairhurst, et al.
Published: (2024-04-01)

‘We have no services for you… so you have to make the best out of it’: A qualitative study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients’ dissatisfaction with healthcare services
by: Line Melby, et al.
Published: (2024-02-01)

Levels of anti-insulin antibodies in diabetic retinopathy patients: an observational cross-sectional study
by: Bismark N Mohammed, et al.
Published: (2024-12-01)

Clinical management of sepsis-associated acute respiratory distress syndrome: current evidence and future directions
by: Liang Liu, et al.
Published: (2025-05-01)

Piloting a team-based telemedicine care for hypertension focused on Black patients
by: Srista Manandhar, et al.
Published: (2025-07-01)

Anti-PGK1 antibodies in immuno-related pancytopenia
by: Shanfeng Hao, et al.
Published: (2025-12-01)

Growing our future: Assessing the outcome of afforestation programs in Ontario, Canada
by: Georgina K. Magnus, et al.
Published: (2021-06-01)

The role of specific pancreatic antibodies in the differential diagnosis of complete clinical and laboratory remission of type 1 diabetes mellitus and MODY in children
by: E. A. Sechko, et al.
Published: (2022-12-01)

Prevalence and prenatal diagnosis of major congenital anomalies in Dubai: first insights and emerging patterns in a multicenter cohort study
by: Anne F. Minsart, et al.
Published: (2025-08-01)

Autoimmune Hepatitis in Children: The Current State of the Problem
by: G. V. Volynets, et al.
Published: (2018-11-01)

ALPHA–2–MACROGLOBULIN COMPLEXES WITH IGG ANTIBODIES, PLASMIN, AND THEIR INTERRELATION WITH OTHER FACTORS OF HUMORAL IMMUNITY DURING THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
by: V. N. Zorina, et al.
Published: (2014-07-01)

Cytisine Use Vs Nicotine Replacement Therapy in Relapsed Smokers with Heart Disease: Feasibility Results from a Pilot Randomized Trial
by: Hassan Mir, MD, MHI, MPH, FRCPC, FACP, et al.
Published: (2025-08-01)

Function focused care in hospital among nurses and patients from geriatric and neurology wards: A mixed method process evaluation
by: Selma Kok, et al.
Published: (2025-12-01)

“There’s just such a mismatch”: a qualitative exploration of health systems and organizational-level barriers to accessing cancer services among people experiencing structural marginalization
by: Tara C. Horrill, et al.
Published: (2025-06-01)

Outcome metrics in recommended performance measurement tools for emergency department performance evaluation: a systematic review
by: Tytti Kristiina Toukola, et al.
Published: (2025-07-01)

APPLICATION OF DIFFERENT LABORATORY METHODS FOR ANTINUCLEAR AUTOANTIBODIES INVESTIGATION IN PATIENTS WITH AUTOIMMUNE CONNECTIVE TISSUE DISEASES
by: I. A. Pashnina, et al.
Published: (2012-05-01)

ASSESSMENTS OF AUTOANTIBODY AND CYTOKINE CONTENTS IN TEENAGERS OF INDUSTRIAL CENTERS SCREENING EXAMINATION
by: L. B. Masnaviyeva, et al.
Published: (2012-05-01)

Erythematous Follicular Papules on the Thighs: A Quiz
by: Shin Iinuma, et al.
Published: (2025-08-01)

Indications and Diagnostic Yield of Paraneoplastic and Autoimmune Encephalitis Antibody Testing: A Retrospective Cohort Study
by: Hannah Ford, et al.
Published: (2025-08-01)

Inflammation Parameters, Xanthine Oxidase and Anti-Xanthine Oxidase Antibodies in Synovial Fluid of Patients Suffering from Arthritis
by: Nadjet Hanachi, et al.
Published: (2022-12-01)

Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma
by: R. U. Shayakhmetova, et al.
Published: (2020-03-01)

TIMP1 secretion induced by Toxoplasma effector GRA24 via p38 MAPK signaling promotes non-disruptive parasite translocation across polarized brain endothelial monolayers
by: Elena Afanaseva, et al.
Published: (2025-05-01)